Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 14, Issue 2, 2008, Pages 242-248

  Phelip, Jean Marc ^a   Ducros, Veronique ^a   Faucheron, Jean Luc ^a   Flourie, Bernard ^b   Roblin, Xavier ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Carcinogenesis; Hyperhomocysteinemia; IBD

Indexed keywords

FOLIC ACID;

ADULT; AGE; ARTICLE; CANCER PATIENT; CARCINOGENESIS; COLON CANCER; COLON TUMOR; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; ENTERITIS; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENDER; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PARAMETER; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING; ULCERATIVE COLITIS; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL;

ADULT; COLONIC NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID DEFICIENCY; FRANCE; HUMANS; HYPERHOMOCYSTEINEMIA; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 39649102151     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20309     Document Type: Article

References (41)

1. Crohn B. Am J Med Sci. 1925;70:220-228.
2. Shanahan F. Relation between colitis and colon cancer. Lancet. 2001;357:246-247.
3. Eaden JA, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a metaanalysis. Gut. 2001;48:526-535.
4. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228-1233.
5. Broome U, Lofberg R, Veress B, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22:1404-1408.
6. Itzkowitz SH, Present DH. Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314-321.
7. Choi PM, Nugent FW, Schoetz DJ Jr, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418-424.
8. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711-714.
9. Velayos FS, Loftus EV Jr, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology. 2006;130:1941-1949.
10. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343:71-74.
11. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994;107:934-944.
12. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology. 2006;131:1271-1283.
13. Roblin X, Germain E, Phelip JM et al. Factors associated with hyperhomocysteinemia in inflammatory bowel disease: prospective study in 81 patients. Rev Med Interne. 2006;27:106-110.
14. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated ans sporadic cancer compared. Trends Mol Med. 2002;8:10-16.
15. Best WR, Becktel JM, Singleton JW et al. Development of a Crohn's disease activity index. Gastroenterology. 1976;70:439-444.
16. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92:1894-1898.
17. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103:1611-20.
18. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(suppl 5):V1-V16.
19. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal neoplasia. Gut. 2000;47:251-255.
20. Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol. 1993;119:549-554.
21. Jess T, Loftus EV Jr, Velayos FS, et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol. 2007;102:829-836.
22. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
23. Laird PW. The power and promise of DNA methylation markers. Nat Rev Cancer. 2003;3:253-266.
24. Kim YI. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr. 2005;135: 2703-2709.
25. Martinez ME, Thompson P, Jacobs ET, et al. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway. Gastroenterology. 2006;131:1706-1716.
26. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine - low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87:265-273.
27. Marugame T, Tsuji E, Kiyohara C, et al. Relation of plasma folate and methylenetetrahydrofolate reductase C677T polymorphism to colorectal adenomas. Int J Epidemiol. 2003;32:64-66.
28. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology. 2001;121:282-301.
29. Van Guelpen B, Hultdin J, Johansson I, et al. Gut. 2006;55:1461-1466.
30. Morgenstern I, Raijmakers MT, Peters WH, et al. Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease. Dig Dis Sci. 2003;48:2083-2090.
31. Poddar R, Sivasubramanian N, DiBello PM, et al. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 2001;103:2717-2723.
32. Kim YI, Pogribny IP, Basnakian AG, et al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr. 1997;65:46-52.
33. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 1997;94:3290-3295.
34. Gudnason V, Stansbie D, Scott J, et al. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR); its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis. 1998;136:347-354.
35. Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci U S A. 1998;95:13217-13220.
36. Pufulete M, Al Ghnaniem R, Leather AJ, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology. 2003;124:1240-1248.
37. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma - carcinoma sequence in large bowel. Lancet. 1978;1:245-247.
38. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006;130:1039-1046.
39. Papa A, De Stefano V, Danese S, et al. Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:2677-2682.
40. Marion JF, Waye JD, Present DH, et al. Methylene Blue dye-spray targeted biopsies are superior to standard colonoscopic surveillance biopsies for detecting dysplasia in patients with ulcerative and Crohn's colitis: a prospective endoscopic trial. Gastroenterology. 2007;132(Suppl 2):A67.
41. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351-2359.